| Reaction Details |
|---|
 | Report a problem with these data |
| Target | Vascular endothelial growth factor A |
|---|
| Ligand | BDBM301825 |
|---|
| Substrate/Competitor | n/a |
|---|
| EC50 | >100000±n/a nM |
|---|
| Citation |  Kawamoto, RM; Wu, S; Evdokimov, AG; Greis, KD; Boyer, AS; Warshakoon, NC Prolyl hydroxylase inhibitors and methods of use US Patent US9598370 Publication Date 3/21/2017 |
|---|
| More Info.: | Get all data from this article, Assay Method |
|---|
| |
| Vascular endothelial growth factor A |
|---|
| Name: | Vascular endothelial growth factor A |
|---|
| Synonyms: | VEGF | VEGF-A | VEGFA | VEGFA_HUMAN | VPF | Vascular endothelial growth factor (VEGF) | Vascular endothelial growth factor A (VEGF) | Vascular endothelial growth factor A (VEGF2) | Vascular permeability factor |
|---|
| Type: | Protein |
|---|
| Mol. Mass.: | 27063.81 |
|---|
| Organism: | Homo sapiens (Human) |
|---|
| Description: | P15692 |
|---|
| Residue: | 395 |
|---|
| Sequence: | MTDRQTDTAPSPSYHLLPGRRRTVDAAASRGQGPEPAPGGGVEGVGARGVALKLFVQLLG
CSRFGGAVVRAGEAEPSGAARSASSGREEPQPEEGEEEEEKEEERGPQWRLGARKPGSWT
GEAAVCADSAPAARAPQALARASGRGGRVARRGAEESGPPHSPSRRGSASRAGPGRASET
MNFLLSWVHWSLALLLYLHHAKWSQAAPMAEGGGQNHHEVVKFMDVYQRSYCHPIETLVD
IFQEYPDEIEYIFKPSCVPLMRCGGCCNDEGLECVPTEESNITMQIMRIKPHQGQHIGEM
SFLQHNKCECRPKKDRARQEKKSVRGKGKGQKRKRKKSRYKSWSVPCGPCSERRKHLFVQ
DPQTCKCSCKNTDSRCKARQLELNERTCRCDKPRR
|
|
|
|---|
| BDBM301825 |
|---|
| n/a |
|---|
| Name | BDBM301825 |
|---|
| Synonyms: | US11426393, Compound Table XV.24 | US9598370, Example 00149 | USRE47437, Example ({3-Hydroxy-5-[3-(2H-tetrazol-5-yl)phenyl]-pyridine-2-carbonyl}-amino)-acetic acid |
|---|
| Type | Small organic molecule |
|---|
| Emp. Form. | C15H12N6O4 |
|---|
| Mol. Mass. | 340.2936 |
|---|
| SMILES | OC(=O)CNC(=O)c1ncc(cc1O)-c1cccc(c1)-c1nn[nH]n1 |$;;;;HN;;;;;;;;;;;;;;;;;;;;$| |
|---|
| Structure | 
|
|---|
Search and Browse
